Revvity Electronic Laboratory Notebook FedRAMP

Description: The National Center for Advancing Translational Sciences, within the U.S. Department of Health and Human Services and National Institutes of Health, seeks twelve months of services to obtain FedRAMP Moderate authorization for Revvity Signals Electronic Laboratory Notebook. The work includes project management, gap remediation, security-control documentation, interoperability assurance, and preparation and submission of the FedRAMP authorization package. The notice identifies Revvity Signals Software Inc. as the sole proprietary owner and requests capability statements by August 14, 2026, while stating that the acquisition is not a request for competitive quotations.